Given that BRAF activity is elevated in SPOP-mutated cancers, elucidation of the SPOP-BRAF regulatory axis in further studies will be helpful in designing therapeutic strategies for SPOP-mutated cancers. This evidence concerns the gene SPOP and cancer.